Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of RQC for AMD [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial evaluating the safety and efficacy of RQC for age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• RQC

Snippet

Sponsor: Paul A Knepper, MD PhD | Conditions: Age-related Macular Degeneration | Phase 2 | Status: COMPLETED